Layer, Chiang, et al. Genome Biology
Rosetta Launches Next-Generation Cancer Diagnostic, Not Alone in Exploring microRNAs as Biomarkers
A review of the National Cancer Institute's online clearinghouse for clinical trial information shows that more than a dozen groups worldwide are either conducting or preparing to launch studies examining miRNA signatures in humans with a variety of diseases.
New to GenomeWeb? Register here quickly.